InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Galovan Scott Michael, 首席财务官. Director active across 1 company, notably Avanos Medical, INC.. Aggregated, 12 filings have been logged. Activity tracked since 6 March 2026. The latest transaction was disclosed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Galovan Scott Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
135,596 股@ US$25.00Common StockSEC:0001606498-26-000111:0
96,121 股0Common StockSEC:0001606498-26-000111:1
96,121 股@ US$25.00Common StockSEC:0001606498-26-000111:2
4,228 股@ US$24.640.0087% mcap39.7% 占其流量Common StockSEC:0001606498-26-000059:0
29,481 股0Common StockSEC:0001606498-26-000040:0
29,481 股0Common StockSEC:0001606498-26-000031:0
29,481 股0Common StockSEC:0001606498-26-000027:0
1,119 股@ US$13.295.4% 占其流量Common StockSEC:0001606498-26-000014:0
5,907 股@ US$13.790.0061% mcap52.0% 占其流量Common StockSEC:0001606498-26-000010:0
2,356 股@ US$13.790.0024% mcap20.7% 占其流量Common StockSEC:0001606498-26-000010:1
1,057 股@ US$13.790.0011% mcap9.3% 占其流量Common StockSEC:0001606498-26-000010:2
2,041 股@ US$13.790.0021% mcap18.0% 占其流量Common StockSEC:0001606498-26-000010:3
12 条申报中的 12 条
About Galovan Scott Michael
Scott Michael Galovan is Chief Financial Officer at Avanos Medical, Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. With a strong background in corporate finance, Scott plays a key role in financial strategy and decision-making. His expertise is essential in ensuring the financial health of Avanos Medical, Inc.
